JOHNSON & JOHNSON Quarterly Other Liabilities, Noncurrent in USD from Q4 2009 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Johnson & Johnson quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2009 to Q2 2024.
  • Johnson & Johnson Other Liabilities, Noncurrent for the quarter ending June 30, 2024 was $14.1B, a 3.4% decline year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $14.1B -$496M -3.4% Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $15.1B +$646M +4.48% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $13.4B +$3.25B +32.1% Dec 31, 2023 10-Q 2024-07-25
Q3 2023 $13.6B +$3.64B +36.7% Oct 1, 2023 10-Q 2023-10-27
Q2 2023 $14.6B +$4.06B +38.6% Jul 2, 2023 10-Q 2023-07-31
Q1 2023 $14.4B +$3.92B +37.4% Apr 2, 2023 10-Q 2023-04-28
Q4 2022 $10.1B -$540M -5.05% Jan 1, 2023 10-K 2024-02-16
Q3 2022 $9.92B -$1.26B -11.3% Oct 2, 2022 10-Q 2022-10-27
Q2 2022 $10.5B -$2.2B -17.3% Jul 3, 2022 10-Q 2022-07-29
Q1 2022 $10.5B -$1.44B -12.1% Apr 3, 2022 10-Q 2022-04-29
Q4 2021 $10.7B -$1.26B -10.5% Jan 2, 2022 10-K 2023-02-16
Q3 2021 $11.2B -$972M -8% Oct 3, 2021 10-Q 2021-10-29
Q2 2021 $12.7B +$1.69B +15.3% Jul 4, 2021 10-Q 2021-07-29
Q1 2021 $11.9B +$997M +9.11% Apr 4, 2021 10-Q 2021-04-30
Q4 2020 $11.9B +$210M +1.79% Jan 3, 2021 10-K 2022-02-17
Q3 2020 $12.1B +$768M +6.75% Sep 27, 2020 10-Q 2020-10-23
Q2 2020 $11B +$932M +9.23% Jun 28, 2020 10-Q 2020-07-24
Q1 2020 $10.9B +$2.02B +22.6% Mar 29, 2020 10-Q 2020-04-29
Q4 2019 $11.7B +$3.15B +36.6% Dec 29, 2019 10-K 2021-02-22
Q3 2019 $11.4B +$2.84B +33.3% Sep 29, 2019 10-Q 2019-10-28
Q2 2019 $10.1B +$821M +8.85% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 $8.93B +$52M +0.59% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $8.59B -$428M -4.75% Dec 30, 2018 10-K 2020-02-18
Q3 2018 $8.54B -$564M -6.2% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $9.28B -$836M -8.26% Jul 1, 2018 10-Q 2018-08-02
Q1 2018 $8.88B -$650M -6.82% Apr 1, 2018 10-Q 2018-05-01
Q4 2017 $9.02B -$519M -5.44% Dec 31, 2017 10-K 2019-02-20
Q3 2017 $9.1B -$312M -3.31% Oct 1, 2017 10-Q 2017-11-02
Q2 2017 $10.1B +$55M +0.55% Jul 2, 2017 10-Q 2017-08-03
Q1 2017 $9.53B -$223M -2.29% Apr 2, 2017 10-Q 2017-05-08
Q4 2016 $9.54B -$705M -6.88% Jan 1, 2017 10-K 2018-02-21
Q3 2016 $9.41B +$111M +1.19% Oct 2, 2016 10-Q 2016-11-04
Q2 2016 $10.1B +$1.09B +12.1% Jul 3, 2016 10-Q 2016-08-04
Q1 2016 $9.75B +$1.15B +13.3% Apr 3, 2016 10-Q 2016-05-10
Q4 2015 $10.2B +$2.21B +27.5% Jan 3, 2016 10-K 2017-02-27
Q3 2015 $9.3B +$1.55B +19.9% Sep 27, 2015 10-Q 2015-10-30
Q2 2015 $8.97B +$1.6B +21.7% Jun 28, 2015 10-Q 2015-07-31
Q1 2015 $8.6B +$1.33B +18.3% Mar 29, 2015 10-Q 2015-05-01
Q4 2014 $8.03B +$180M +2.29% Dec 28, 2014 10-K 2016-02-24
Q3 2014 $7.76B -$1.14B -12.8% Sep 28, 2014 10-Q 2014-10-30
Q2 2014 $7.37B -$1.2B -14% Jun 29, 2014 10-Q 2014-08-01
Q1 2014 $7.27B -$926M -11.3% Mar 30, 2014 10-Q 2014-05-02
Q4 2013 $7.85B -$698M -8.16% Dec 29, 2013 10-K 2015-02-24
Q3 2013 $8.9B -$312M -3.39% Sep 29, 2013 10-Q 2013-11-04
Q2 2013 $8.57B -$918M -9.68% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $8.2B -$2.34B -22.2% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $8.55B -$2.08B -19.6% Dec 30, 2012 10-K 2014-02-21
Q3 2012 $9.21B +$1.73B +23.2% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $9.49B +$2.26B +31.3% Jul 1, 2012 10-Q 2012-08-02
Q1 2012 $10.5B +$3.54B +50.5% Apr 1, 2012 10-Q 2012-05-07
Q4 2011 $10.6B +$4.06B +61.9% Jan 1, 2012 10-K 2013-02-22
Q3 2011 $7.47B +$1.25B +20% Oct 2, 2011 10-Q 2011-11-08
Q2 2011 $7.23B +$868M +13.7% Jul 3, 2011 10-Q 2011-08-09
Q1 2011 $7B +$958M +15.9% Apr 3, 2011 10-Q 2011-05-10
Q4 2010 $6.57B +$620M +10.4% Jan 2, 2011 10-K 2012-02-23
Q3 2010 $6.23B Oct 3, 2010 10-Q 2010-11-10
Q2 2010 $6.36B Jul 4, 2010 10-Q 2010-08-11
Q1 2010 $6.04B Apr 4, 2010 10-Q 2010-05-10
Q4 2009 $5.95B Jan 3, 2010 10-K 2011-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.